Study of Naltrexone for Methamphetamine Addiction

California Pacific Medical Center Research Institute22 enrolled

Overview

The purpose of this study is to determine whether methamphetamine-dependent individuals will use less methamphetamine when treated with naltrexone. The study will also investigate whether individuals with the mu opioid receptor gene variant A118G will use less methamphetamine than individuals without A118G.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Methamphetamine Dependence

Interventions

NaltrexoneDRUG

380mg extended-release, given once by intramuscular gluteal injection

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age between 18 and 50 years * Patient is agreeable to conditions of study and signs consent form

Locations (1)

Addiction & Pharmacology Research Laboratory

San Francisco, California, United States

Outcomes

Primary Outcomes

MA (-) Urine Samples

Time frame: Twice weekly for 5 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.